查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1572018

经皮肾结石清除的全球市场

Percutaneous Nephrolithotomy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球经皮肾结石清除市场预计将达到 4.452 亿美元

经皮镜取石术的全球市场预计 2023 年为 3.284 亿美元，预计到 2030 年将达到 4.452 亿美元，预测在 2023-2030 年分析期间复合年增长率为 4.4%。

美国市场预估为8,770万美元，中国预期复合年增长率为6.6%

预计 2023 年美国经皮取石术市场规模将达 8,770 万美元。中国作为世界第二大经济体，预计到 2030 年市场规模将达到 9,360 万美元，2023-2030 年分析期间复合年增长率为 6.6%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.5% 和 4.2%。在欧洲，德国的复合年增长率预计为 2.7%。

全球经皮皮肾结石清除市场 – 主要趋势与驱动因素

什么是经皮皮肾结石清除术？

经皮镜取石术（PCNL）用于清除无法透过体外震波碎石术（ESWL）或输尿管镜检查等微创技术有效治疗的大型或复杂肾结石。但PCNL有什么特点以及为什么选择它来治疗大肾结石呢？此手术需要在患者背部切割一个小切口（通常小于 1 公分），然后将肾镜（一种特殊的手术器械）直接插入肾臟。这使得外科医生能够看到结石并使用器械将其打碎并取出。通常会暂时放置一根管子，以确保手术后适当引流和癒合。 PCNL 对于直径大于 2 公分的结石、棘状结石和位于肾臟内困难解剖位置的结石特别有效。此手术效率很高，大多数情况下结石清除率超过 90%，使其成为一次治疗大结石或多颗结石的好选择。与开放性手术相比，PCNL具有术后疼痛轻度、住院时间短、恢復快等优点，为复杂肾结石需要明确解决方案的患者带来巨大益处。

最近的技术进展如何提高 PCNL 的安全性和有效性？

经皮肾结石清除领域极大地受益于技术进步，显着提高了手术的安全性、准确性和结果。最显着的进步之一是手术器械的小型化，允许使用更小的肾镜和称为迷你 PCNL 和超迷你 PCNL 的接入管进行手术。此手术适用于儿童和成人患者，因为它可以降低出血风险并最大限度地减少对肾臟的创伤。另一个关键创新是使用先进的显像模式，例如透视、超音波和即时 CT 引导，以实现更精确的结石定位和更安全的肾臟，即使在解剖结构复杂的情况下也是如此。此外，更新的碎石设备，包括雷射和气动设备，增加了碎石的能力，减少了翻修手术的需要。这些能源来源提高了效率，使外科医生能够更快地打碎较大的结石，同时保护健康组织。 PCNL 机器人技术和电脑辅助导航的整合也即将到来，预计将进一步提高泌尿系统的准确性并缩短学习曲线。此外，单步扩张技术和球囊扩张器简化了肾造口术的製作过程，减少了手术时间和併发症率。这些进步使得PCNL不仅更安全，而且适用于更广泛的患者群体，包括具有复杂肾臟解剖结构、单一肾臟和多种併发症的患者，使其更符合现代泌尿系统，效用正在扩大。

为什么 PCNL 成为各种患者群体的首选治疗方法？

经皮取石术在不同患者群体中的采用率稳步增加，反映了其在复杂结石疾病中的多功能性和有效性。在成年人中，PCNL 正在成为治疗大结石、多发性结石以及非侵入性方法失败时的首选。 PCNL 具有较高的结石清除成功率和相对较低的復发率，使其成为寻求结石疾病明确解决方案的患者的一个有吸引力的选择。由于小型仪器和低风险手术的发展，小儿泌尿系统是 PCNL 变得越来越流行的另一个领域。对于儿童来说，PCNL 为治疗有症状的结石提供了安全的选择，否则需要多次手术。经常患有多种併发症的老年患者也受益于 PCNL 的微创特性，与开放性手术相比，其併发症率较低。此外，由于手术的高度适应性以及外科医生使用专用设备的能力，患有独特解剖学挑战的患者（例如患有马蹄肾或孤立性肾病的患者）越来越多地接受 PCNL。 PCNL 的范围正在进一步扩大，包括肥胖患者，经皮方法比更具侵入性的选择具有明显的优势，可以减少手术负担和恢復时间。 PCNL 在如此多样化的患者群体中得到广泛接受，不仅证明了该手术的多功能性，而且还证明了泌尿系统定制 PCNL 手术以满足不同患者群体的特定需求的能力。

是什么推动了经皮肾结石清除市场的成长？

经皮肾结石市场的成长受到多种因素的推动，例如技术进步、肾结石盛行率上升以及患者和临床医生对微创选择的认识不断提高。主要成长要素之一是全球肾结石盛行率上升，这与饮食习惯、肥胖、代谢异常等生活方式因素密切相关。随着肾结石在各个年龄层变得越来越常见，对 PCNL 等有效手术治疗的需求不断增长。此外，手术设备和诊断影像设备的技术创新提高了 PCNL 的安全性和准确性，使其成为更广泛的患者的可行选择，包括那些具有复杂解剖结构和高风险特征的患者。随着更小型仪器的出现，PCNL 的患者群体正在扩大，特别是在儿科和老年医学领域，传统的 PCNL 被认为侵入性太强。另一个重要因素是患者和医疗保健提供者越来越偏好微创手术，从而缩短復原时间、减少併发症并改善美容效果。泌尿系统专科中心的增加以及接受过先进 PCNL 技术培训的熟练外科医生的出现也有助于市场扩张。此外，监管机构对新 PCNL 设备的核准以及旨在改善专业外科护理机会的支持性医疗政策正在鼓励更广泛的采用。机器人系统和电脑辅助导航的整合有望进一步推动市场，因为它是一项有望提高准确性并缩短程式学习曲线的技术。这些因素共同塑造了 PCNL 市场的发展轨迹，并随着对有效微创肾结石治疗的需求持续上升，使其实现强劲成长。

受访企业范例（共42例）

  • Boston Scientific Corporation
  • Cook Medical
  • Electro Medical Systems SA
  • innoMedicus AG
  • Karl Storz Se & Co. KG
  • Olympus Corporation
  • PolyDiagnost

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP17592

Global Percutaneous Nephrolithotomy Market to Reach US$445.2 Million by 2030

The global market for Percutaneous Nephrolithotomy estimated at US$328.4 Million in the year 2023, is expected to reach US$445.2 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030.

The U.S. Market is Estimated at US$87.7 Million While China is Forecast to Grow at 6.6% CAGR

The Percutaneous Nephrolithotomy market in the U.S. is estimated at US$87.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$93.6 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Percutaneous Nephrolithotomy Market - Key Trends and Drivers Summarized

What Is Percutaneous Nephrolithotomy and Why Is It the Preferred Treatment for Large Kidney Stones?

Percutaneous Nephrolithotomy (PCNL) is a minimally invasive surgical procedure used to remove large or complex kidney stones that cannot be effectively treated through less invasive techniques such as extracorporeal shock wave lithotripsy (ESWL) or ureteroscopy. But what makes PCNL distinct and why is it the go-to choice for large renal calculi? The procedure involves making a small incision, usually less than one centimeter, in the patient’s back through which a nephroscope—a specialized surgical instrument—is inserted directly into the kidney. This allows the surgeon to visualize the stones and use instruments to break them into smaller pieces for removal. A tube is often placed temporarily to ensure proper drainage and healing post-procedure. PCNL is particularly effective for stones larger than 2 cm in diameter, staghorn stones, or when stones are located in challenging anatomical locations within the kidney. The technique is highly efficient, with a stone clearance rate exceeding 90% in most cases, making it the preferred option for treating large or multiple stones in a single setting. Compared to open surgery, PCNL is associated with less postoperative pain, shorter hospital stays, and quicker recovery times, providing a significant advantage to patients who need a definitive solution to complex kidney stones.

How Have Recent Technological Advances Enhanced the Safety and Efficacy of PCNL?

The field of Percutaneous Nephrolithotomy has benefited immensely from technological advancements that have significantly improved the safety profile, precision, and outcomes of the procedure. One of the most noteworthy developments is the miniaturization of surgical instruments, leading to what is known as mini-PCNL or ultra-mini-PCNL, which uses even smaller nephroscopes and access tracts. This technique reduces the risk of bleeding and minimizes trauma to the kidney, making it suitable for pediatric patients and adults alike. Another pivotal innovation is the use of advanced imaging modalities, such as fluoroscopy, ultrasound, and real-time CT guidance, which allow for more precise stone targeting and safer access to the kidney, even in anatomically complex cases. Furthermore, new lithotripters, including laser and pneumatic devices, provide enhanced power for fragmenting hard stones, thus reducing the need for repeat procedures. These energy sources have improved efficiency, allowing surgeons to break down larger stones more quickly while preserving healthy tissue. The integration of robotics and computer-assisted navigation in PCNL is also on the horizon, promising to further increase accuracy and reduce the learning curve for urologists. Additionally, single-step dilation techniques and balloon dilators have simplified the process of creating the nephrostomy tract, decreasing operative time and lowering the incidence of complications. With these advancements, PCNL has become not only safer but also more adaptable to a wider range of patient profiles, including those with complex renal anatomy, solitary kidneys, or multiple co-morbidities, thereby expanding its utility in modern urological practice.

Why Is PCNL Becoming the Preferred Treatment Option Across Different Patient Demographics?

The adoption of Percutaneous Nephrolithotomy is steadily increasing across various patient demographics, reflecting its versatility and efficacy in addressing complex stone disease. In adult populations, PCNL is becoming the first-line option for managing large or multiple stones, as well as for cases where non-invasive methods have failed. The procedure’s high success rate in clearing stones, combined with its relatively low recurrence rate, makes it an attractive choice for patients seeking a definitive solution to their condition. Pediatric urology is another area where PCNL is gaining traction, thanks to the development of miniaturized instruments and lower-risk techniques. In children, PCNL offers a safe alternative for treating symptomatic stones that would otherwise require multiple procedures. Elderly patients, who often present with multiple comorbid conditions, also benefit from PCNL’s minimally invasive nature, which results in a lower overall complication rate compared to open surgery. Moreover, individuals with unique anatomical challenges, such as horseshoe kidneys or patients with a solitary kidney, are increasingly undergoing PCNL due to the procedure’s adaptability and the surgeon’s ability to tailor the approach using specialized equipment. The application of PCNL is further expanding to include obese patients, where the percutaneous approach offers a clear advantage over more invasive options, reducing surgical stress and recovery time. This broadening acceptance of PCNL across diverse patient groups is not just a testament to the procedure’s versatility but also to the growing expertise of urologists in customizing PCNL techniques to meet the specific needs of different patient populations.

What’s Fueling the Growth of the Percutaneous Nephrolithotomy Market?

The growth in the Percutaneous Nephrolithotomy market is driven by several factors, including technological advancements, the rising incidence of kidney stone disease, and increasing patient and clinician awareness of minimally invasive options. One of the primary growth drivers is the global rise in the prevalence of nephrolithiasis, which is closely linked to lifestyle factors such as dietary habits, obesity, and metabolic disorders. With kidney stone disease becoming more common across age groups, there is a growing demand for effective surgical treatments like PCNL. Additionally, technological innovations in surgical equipment and imaging modalities are enhancing the safety and precision of PCNL, making it a more viable option for a broader range of patients, including those with complex anatomy or high-risk profiles. The availability of miniaturized instruments has expanded the patient base for PCNL, particularly in pediatric and geriatric care, where traditional PCNL might have been deemed too invasive. Another key factor is the increasing preference among patients and healthcare providers for minimally invasive procedures, which are associated with shorter recovery times, fewer complications, and better cosmetic outcomes. The growth of specialized urology centers and the presence of skilled surgeons who are trained in advanced PCNL techniques are also contributing to market expansion. Moreover, regulatory approval of new PCNL devices and supportive healthcare policies aimed at improving access to specialized surgical care are encouraging more widespread adoption. The integration of robotic systems and computer-assisted navigation is poised to further propel the market, as these technologies promise to enhance precision and reduce the procedural learning curve. Collectively, these factors are shaping the trajectory of the PCNL market, positioning it for robust growth as the demand for effective and minimally invasive kidney stone treatments continues to rise.

Select Competitors (Total 42 Featured) -

  • Boston Scientific Corporation
  • Cook Medical
  • Electro Medical Systems SA
  • innoMedicus AG
  • Karl Storz Se & Co. KG
  • Olympus Corporation
  • PolyDiagnost

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Percutaneous Nephrolithotomy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Kidney Stones Globally Spurs Demand for Minimally Invasive Surgical Techniques
    • Advancements in Imaging Technologies Strengthen the Business Case for PCNL in Complex Stone Management
    • Rising Adoption of Miniaturized Instruments Expands Addressable Market Opportunity in Pediatric and Geriatric Segments
    • Integration of Robotics and Computer-Assisted Navigation Propels Market Growth in High-Precision Stone Removal
    • Improved Post-Operative Outcomes and Reduced Recovery Times Sustain Growth of PCNL in High-Risk Patient Groups
    • Surge in Health Awareness and Early Diagnosis Accelerates Demand for Surgical Stone Management Solutions
    • Technological Innovations in Lithotripters and Energy Sources Strengthen PCNL's Position in the Kidney Stone Treatment Spectrum
    • Rising Geriatric Population and Associated Urological Disorders Expand the Addressable Market for PCNL
    • Increasing Medical Tourism in Emerging Markets Generates New Opportunities for PCNL Procedures
    • High Incidence of Lifestyle-Related Risk Factors for Nephrolithiasis Creates Sustained Demand for Surgical Interventions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Percutaneous Nephrolithotomy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • JAPAN
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CHINA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • EUROPE
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Percutaneous Nephrolithotomy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: Europe 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • GERMANY
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED KINGDOM
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SPAIN
    • TABLE 24: Spain Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Spain Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • RUSSIA
    • TABLE 26: Russia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Russia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF EUROPE
    • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Rest of Europe Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ASIA-PACIFIC
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 31: Asia-Pacific Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 32: Asia-Pacific 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 33: Australia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 34: Australia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • INDIA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 35: India Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: India Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SOUTH KOREA
    • TABLE 37: South Korea Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 38: South Korea Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF ASIA-PACIFIC
    • TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 40: Rest of Asia-Pacific Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • LATIN AMERICA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 41: Latin America Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: Latin America Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Latin America 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 44: Argentina Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Argentina Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • BRAZIL
    • TABLE 46: Brazil Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Brazil Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • MEXICO
    • TABLE 48: Mexico Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Mexico Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF LATIN AMERICA
    • TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Latin America Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • MIDDLE EAST
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 52: Middle East Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 53: Middle East Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 54: Middle East 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 55: Iran Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 56: Iran Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ISRAEL
    • TABLE 57: Israel Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 58: Israel Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SAUDI ARABIA
    • TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Saudi Arabia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED ARAB EMIRATES
    • TABLE 61: UAE Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 62: UAE Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF MIDDLE EAST
    • TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 64: Rest of Middle East Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • AFRICA
    • Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 65: Africa Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Africa Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

IV. COMPETITION